IP Library Granted Patent US 7,371,526
Granted Patent B2
US 7,371,526 · App. 10/926,531 · Granted May 13, 2008

Method and materials for bisulfite conversion of cytosine to uracil

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,526
App. No.
10/926,531
Granted
May 13, 2008
Kind
B2
Abstract

The invention provides methods and materials for conversion of cytosine to uracil. In some embodiments, a nucleic acid, such as gDNA, is reacted with at least one bisulfite salt having the formula X + HSO 3 − or Y +2 (HSO 3 31 ) 2 ; wherein X + is ammonium ion, a tetraalkyl ammonium ion, or a group 1A ion other than sodium; and Y +2 is a group 2A ion or a group 7B ion; under conditions effective to convert at least one cytosine nucleobase to a uracil nucleobase. In some embodiments, X + comprises at least one of lithium ion, potassium ion, ammonium ion, tetraalkylammonium ion, magnesium ion, manganese ion and calcium ion. In some embodiments, the reacting is performed optionally in the presence of a polyamine catalyst and/or a quaternary amine catalyst. Also provided are kits that can be used to carry out methods of the invention.

Claims (21)

1. In a method of converting at least one cytosine nucleobase to a uracil nucleobase in a nucleic acid wherein the nucleic acid is treated with bisulfite ion, the improvement comprising:

performing said treatment of the nucleic acid with bisulfite ion in the presence of Mg 2+ ion.

2. The method of claim 1 , wherein said treatment is performed in a solution containing magnesium bisulfite in a concentration of from about 0.5M to about 2.5M.

3. The method of claim 2 , wherein said solution contains magnesium bisulfite in a concentration of 1M to 2M.

4. The method of claim 1 , wherein said treatment is performed at 40 degrees to 60 degrees for 4 to 15 hours.

5. The method of claim 1 , wherein said nucleic acid is gDNA.

6. The method of claim 1 , wherein said nucleic acid is obtained from microorganisms.

7. The method of claim 2 , wherein said nucleic acid is obtained from DNA or RNA viruses.

8. The method of claim 1 , further comprising treating the product of said reaction of said nucleic acid and said bisulfite ion with a base.

9. The method of claim 8 , wherein said base comprises NaOH.

10. A kit for use in converting at least one cytosine nucleobase to a uracil nucleobase in a nucleic acid wherein the nucleic acid is treated with bisulfite ion, the improvement comprising:

performing said treatment of the nucleic acid with bisulfite ion in the presence of Mg 2+ ion.

11. The kit of claim 10 , wherein the bisulfite ion and the Mg 2+ ion are present as magnesium bisulfite.

12. The kit of claim 10 , wherein said treatment is performed in a solution containing magnesium bisulfite in a concentration of from about 0.5M to about 2.5M.

13. The kit of claim 10 , wherein said solution contains magnesium bisulfite in a concentration of 1M to 2M.

14. The kit of claim 10 , wherein said treatment is performed at 40 degrees to 60 degrees for 4 to 15 hours.

15. The kit of claim 10 , wherein said nucleic acid is gDNA.

16. The kit of claim 10 , wherein said nucleic acid is obtained from microorganisms.

17. The kit of claim 10 , wherein said nucleic acid is obtained from DNA or RNA viruses.

18. The kit of claim 10 , further comprising treating the product of said reaction of said nucleic acid and said bisulfite ion with a base.

19. The kit of claim 18 , wherein said base comprises NaOH.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVNG PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038003/0001 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2004
From: BOYD, VICTORIA L.; ZON, GERALD
To: APPLERA CORPORATION
Reel/Frame 015493/0756 →